Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus

Citation
Jc. King et al., Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus, J INFEC DIS, 181(5), 2000, pp. 1817-1821
Citations number
13
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00221899 → ACNP
Volume
181
Issue
5
Year of publication
2000
Pages
1817 - 1821
Database
ISI
SICI code
0022-1899(200005)181:5<1817:GALSIP>2.0.ZU;2-S
Abstract
Pneumococcal antibody levels surrounding systemic pneumococcal illness (SPI ) were measured in children infected with human immunodeficiency virus (HIV ). Archived serum samples were collected from 28 HIV-infected children who had 34 cases of SPI, caused by pneumococcal groups 4, 6, 9, 14, 19, and 23. Serum samples collected within 23 weeks before and 13 weeks after the SPI were assayed by ELISA for antipneumococcal polysaccharide (PnPs) IgG antibo dy to 6 representative pneumococcal serotypes, There was a wide range (0.16 -30.80 mu g/mL) of pre-SPI anti-PnPs antibody levels to the presumed infect ing serotypes, with a geometric mean level of 0.83 mu g/mL (n = 34), Sevent y-six percent of the antibody values were <2.0 mu g/mL and 95% were <5.0 mu g/mL. Homologous seroresponses (greater than or equal to 4-fold rise in an ti-PnPs antibody) were detected in only 4 (27%) of 15 paired serum samples. Heterologous, noninfecting group seroresponses were detected frequently (7 2%) in the paired serum samples from these 4 homologous group seroresponder s.